REX
REX American Resources Corporation
NYSE · Basic Materials · Chemicals - Specialty · US
$41.52
−0.24%Year over year
Reported trailing growth
- Revenue
- +2.5%
- EBITDA
- +64.5%
- EBIT
- +71.7%
- EPS
- +145.8%
- Free cash flow
- +508.3%
- Operating cash flow
- +100.6%
Forward estimates
Based on analyst estimates
- Revenue
- -38.9%
- EBITDA
- -59.5%
- EPS
- -74.5%
Three-year CAGR
- Revenue
- -8.7%
- EBITDA
- +14.2%
- EBIT
- +33.3%
- Net income
- +44.1%
- EPS
- +47.1%
- Free cash flow
- +8.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026